2.10
price down icon4.98%   -0.11
after-market Handel nachbörslich: 2.11 0.010 +0.48%
loading
Schlusskurs vom Vortag:
$2.21
Offen:
$2.15
24-Stunden-Volumen:
1.47M
Relative Volume:
0.58
Marktkapitalisierung:
$62.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.08M
KGV:
-4.7554
EPS:
-0.4416
Netto-Cashflow:
-
1W Leistung:
+85.84%
1M Leistung:
+19.32%
6M Leistung:
-57.83%
1J Leistung:
-47.76%
1-Tages-Spanne:
Value
$2.03
$2.23
1-Wochen-Bereich:
Value
$1.1401
$3.10
52-Wochen-Spanne:
Value
$1.12
$8.40

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Name
Firmenname
Telomir Pharmaceuticals Inc
Name
Telefon
786-396-6723
Name
Adresse
100 SE 2ND ST, MIAMI
Name
Mitarbeiter
5
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
TELO's Discussions on Twitter

Vergleichen Sie TELO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TELO
Telomir Pharmaceuticals Inc
2.10 33.63M 0 -13.08M 0 -0.4416
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-21 Eingeleitet Rodman & Renshaw Buy

Telomir Pharmaceuticals Inc Aktie (TELO) Neueste Nachrichten

pulisher
01:37 AM

What analysts say about Telomir Pharmaceuticals Inc. stockSuperior returns - jammulinksnews.com

01:37 AM
pulisher
10:56 AM

Is Telomir Pharmaceuticals Inc. a good long term investmentRecord-setting profit potential - jammulinksnews.com

10:56 AM
pulisher
08:28 AM

What drives Telomir Pharmaceuticals Inc. stock priceDynamic profit opportunities - jammulinksnews.com

08:28 AM
pulisher
06:38 AM

What makes Telomir Pharmaceuticals Inc. stock price move sharplyGrowth Stock Monitor - Newser

06:38 AM
pulisher
Jul 21, 2025

Pre-market Movers: PMN, GCTK, TELO, SRPT... - RTTNews

Jul 21, 2025
pulisher
Jul 19, 2025

Telomir Pharmaceuticals Inc. Stock Analysis and ForecastExceptional gains - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Why Is Telomir Pharmaceuticals Stock (TELO) Up 150% Today? - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

Healthcare Stocks Move in Pre-Market Session: Telomir Pharmaceuticals, Mesoblast, and More - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Demonstrates Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin - Lohud

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharmaceuticals Stock Price, Quotes and Forecasts - Benzinga

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir skyrockets on preclinical data backing epigenetic potential of lead asset - FirstWord Pharma

Jul 18, 2025
pulisher
Jul 18, 2025

Dow Falls Over 200 Points; 3M Earnings Top Views - Benzinga

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharma Skyrockets Nearly 139% After-Hours As Cancer Drug Shows Breakthrough Results, Beats Chemo In Human Cell Tests - NewsBreak: Local News & Alerts

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharmaceuticals Skyrockets 150% on Breakthrough Preclinical Cancer Results - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharmaceuticals: A Disruptive Force in Prostate Cancer Therapy with Epigenetic Innovation - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharmaceuticals stock soars after promising cancer treatment data - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharma Jumps In After-Hours Trading After Drug Reverses Damage In Progeria Cells; Retail Eyes Bigger Gains - Stocktwits

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharmaceuticals stock soars after promising cancer treatment data By Investing.com - Investing.com UK

Jul 18, 2025
pulisher
Jul 18, 2025

Cancer Breakthrough Sends Telomir Pharma Stock Exploding 157% - Wall Street Pit

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir-1 shows stronger epigenetic effects than standard drugs in cancer study - Investing.com Australia

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir-1 shows stronger epigenetic effects than standard drugs in cancer study By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

Revolutionary Cancer Treatment Shows 50% Tumor Reduction, Beats Standard Chemotherapy in Clinical Tests - Stock Titan

Jul 18, 2025
pulisher
Jul 18, 2025

TELO’s Stock Tango: The Dance of Gains and Losses in 2025 - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Published on: 2025-07-18 16:06:06 - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharmaceuticals Stock Soars 123.97% on Promising Cancer Drug Data - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharma Jumps In After-Hours Trading After Drug Reverses Damage In Progeria Cells Retail Eyes Bigger Gains - Menafn.com

Jul 18, 2025
pulisher
Jul 17, 2025

Telomir says data show Telomir-1 reversed epigenetic silencing - TipRanks

Jul 17, 2025
pulisher
Jul 15, 2025

How Telomir Pharmaceuticals Inc. stock performs during market volatilityProfit Focused Trade Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Telomir Pharmaceuticals Inc. stock attracts strong analyst attentionStable Stocks With High Yield - Newser

Jul 15, 2025

Finanzdaten der Telomir Pharmaceuticals Inc-Aktie (TELO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):